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Introduction
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 
is the most aggressive form of  small vessel disease of  the brain leading to premature stroke and vascular 
dementia (1). It is caused by NOTCH3 mutations (2) and is the commonest monogenetic form of  stroke 
(3). CADASIL is a devastating condition because it affects adults in their prime years with the age of  onset 
about 30 years, it is progressive, it is commonly associated with depression and psychiatric disorders, and 
there are no mechanism-specific treatments (1–4).
Although CADASIL manifests clinically as a vascular disease of the brain, all small- and medium-sized 
arteries are likely affected by CADASIL-causing NOTCH3 mutations (5, 6). It is therefore possible that these 
mutations also cause vascular abnormalities peripherally. However, there is a paucity of information about the 
systemic microvasculature in CADASIL, with some studies reporting endothelial dysfunction in peripheral and 
retinal arteries, while others demonstrate normal endothelial function with altered vascular reactivity (7–12).
Notch3, composed of  an extracellular domain (ECD), a transmembrane domain, and an intracellu-
lar domain (ICD), regulates the structural and functional integrity of  small arteries. Unlike other Notch 
isoforms (Notch1, -2, and -4), Notch3 is expressed almost exclusively in vascular smooth muscle cells 
(VSMCs) (13). CADASIL-causing NOTCH3 mutations lead to progressive degeneration of  VSMCs, 
accumulation of  abnormal protein (granular osmiophilic material [GOM]) around VSMCs, and vascular 
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 
(CADASIL) leads to premature stroke and vascular dementia. Mechanism-specific therapies 
for this aggressive cerebral small vessel disease are lacking. CADASIL is caused by NOTCH3 
mutations that influence vascular smooth muscle cell (VSMC) function through unknown 
processes. We investigated molecular mechanisms underlying the vasculopathy in CADASIL 
focusing on endoplasmic reticulum (ER) stress and RhoA/Rho kinase (ROCK). Peripheral small 
arteries and VSMCs were isolated from gluteal biopsies of CADASIL patients and mesentery of 
TgNotch3R169C mice (CADASIL model). CADASIL vessels exhibited impaired vasorelaxation, blunted 
vasoconstriction, and hypertrophic remodeling. Expression of NOTCH3 and ER stress target 
genes was amplified and ER stress response, Rho kinase activity, superoxide production, and 
cytoskeleton-associated protein phosphorylation were increased in CADASIL, processes associated 
with Nox5 upregulation. Aberrant vascular responses and signaling in CADASIL were ameliorated by 
inhibitors of Notch3 (γ-secretase inhibitor), Nox5 (mellitin), ER stress (4-phenylbutyric acid), and 
ROCK (fasudil). Observations in human CADASIL were recapitulated in TgNotch3R169C mice. These 
findings indicate that vascular dysfunction in CADASIL involves ER stress/ROCK interplay driven by 
Notch3-induced Nox5 activation and that NOTCH3 mutation–associated vascular pathology, typical 
in cerebral vessels, also manifests peripherally. We define Notch3-Nox5/ER stress/ROCK signaling 
as a putative mechanism-specific target and suggest that peripheral artery responses may be an 
accessible biomarker in CADASIL.
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dysfunction (2, 14). In the brain, these processes present as subcortical lacunas and white matter injury 
and manifest clinically as premature stroke, dementia, cognitive decline, and migraines (1, 3, 15). While 
the clinical characteristics of  CADASIL are well defined, the molecular and cellular processes underly-
ing the vasculopathy are poorly understood.
Putative mechanisms have been studied in experimental models of  CADASIL (TgNotch3R169C mice) 
and immortalized human cell lines. Studies in TgNotch3R169C mice demonstrated that cerebrovascular dys-
function is associated with upregulation of  voltage-dependent potassium (Kv1) channels, blunted membrane 
depolarization, and reduced myogenic tone due to increased levels of  metallopeptidase inhibitor TIMP3 
(16–18). To date, these processes have not been demonstrated in human disease. Cell-based studies using 
cultured umbilical VSMCs from a CADASIL patient reported increased expression of  proteins involved in 
protein degradation/folding, cytoskeletal organization, contraction, and cell stress (19). In human induced 
pluripotent stem cells generated from CADASIL somatic cells and in skin fibroblasts of  CADASIL patients, 
increased platelet-derived growth factor (PDGF) signaling, enhanced TGF-β expression, endoplasmic retic-
ulum (ER) retention of  mutant Notch3 aggregates, and oxidative and ER stress have been described (20–24).
ER stress is a cellular response to the accumulation of  unfolded/misfolded proteins in the ER and has 
been implicated in vascular dysfunction in cardiovascular disease (25, 26). Beyond its role in the processing 
of  cellular proteins, ER stress influences VSMC function through its effects on Ca2+ handling, oxidative 
stress, and signaling molecules, including Rho kinase (27). Calcium and RhoA/Rho kinase are critically 
involved in controlling VSMC contraction, migration, growth, and cytoskeletal organization and increased 
Rho kinase activity has been demonstrated in many models of  vascular dysfunction (28, 29).
A relationship between ER stress and Rho kinase has been demonstrated in VSMCs (30) and experi-
mental models of  vascular damage, where the ER stress response promotes activation of  Rho kinase (30, 
31). These phenomena may be regulated by Notch3-dependent processes because Notch3 associates with 
the protein-folding chaperone binding immunoglobulin protein (BiP; also known as GRP78) in the ER 
(32), mutations in Notch3 cause formation and retention of  aggregates in the ER (23), and Notch3 modu-
lates vascular RhoA/Rho kinase signaling (33). Accordingly, it is plausible that abnormal signaling through 
Notch3 and its downstream targets plays a role in vascular injury and dysfunction in CADASIL.
We hypothesized that aberrant Notch3 function promotes ER and oxidative stress and activation of  
RhoA/Rho kinase, which alter VSMC growth and cytoskeletal organization, processes leading to impaired 
vascular function in CADASIL. ER stress and Rho kinase are clinically important druggable targets 
because FDA-approved drugs that inhibit these targets are available. We interrogated these processes in 
disease-appropriate small arteries and VSMCs from clinically phenotyped CADASIL patients. We also 
used a reverse-translation approach in transgenic mice (TgNotch3R169C) that express the CADASIL-causing 
Notch3(R169C) mutant protein (6).
Results
Clinical features of  subjects. We studied 20 CADASIL patients (30–62 years old, 55% female), who carry 
between them 13 different NOTCH3 genetic mutations, all of  which involve cysteine residues encoded in 
exons 2 to 6. The clinical features, genetics, and demographic of  the CADASIL patients are reported in 
Supplemental Table 2; supplemental material available online with this article; https://doi.org/10.1172/
jci.insight.131344DS1. Eleven normotensive, healthy subjects on no medication and with no history of  
cardiovascular disease (34–58 years, 60% female) were studied as controls. Pulse wave velocity, which is 
an important clinical parameter to evaluate cardiovascular risk, was recorded in patients (7.84 ± 0.34 m/s) 
and found to be similar to published age-related normal values (34) and not different from our previously 
reported results in CADASIL patients (15). These findings indicate that the stiffness of  large arterial vessels 
is not altered in CADASIL.
Altered function, structure, and mechanical properties of  peripheral small arteries in CADASIL. Small resis-
tance arteries from gluteal biopsies were studied by wire and pressure myography to assess vascular 
contraction, relaxation, and structural properties. In vessels from healthy control subjects, maximal 
agonist-induced vasorelaxation (endothelium-dependent and -independent) and vasoconstriction were 
approximately 100% (Figure 1), as we and others have previously reported (35, 36). In small arteries 
from CADASIL patients, acetylcholine-induced (ACh-induced) vasorelaxation (endothelium-depen-
dent) was significantly impaired, with maximal dilatory responses of  20%–30%, compared with 90%–
100% in control vessels (Figure 1A). These effects in CADASIL were slightly ameliorated in vessels 
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pretreated with the ROS scavenger N-acetyl cysteine (NAC) (Figure 1B). Sodium nitroprusside–induced 
(SNP-induced) vasorelaxation (endothelium-independent) (Figure 1C) was also significantly reduced 
relative to controls. Contractile responses to phenylephrine (PE) were decreased in CADASIL vessels 
compared with vessels from healthy controls (Figure 1D). Similar attenuated vasoconstriction was also 
evident for angiotensin II (Ang II), where maximal contractile responses were decreased in CADASIL 
vessels (Supplemental Figure 1).
Vascular structure was altered in CADASIL subjects. While there were no changes in the external and 
internal diameters of  CADASIL vessels relative to control vessels (Figure 2, A and B), the vascular wall 
(media) thickness and the media/lumen ratio were significantly greater in CADASIL vessels compared with 
controls (Figure 2, C and D), suggestive of  hypertrophic remodeling (37). Mechanical properties (circum-
ferential vessel wall stress, strain) were studied in pressurized vessels. Changes in circumferential vessel wall 
stress and strain under increasing intraluminal pressure showed a significant rightward shift in CADASIL ver-
sus control arteries, indicating reduced stiffness, or increased elasticity, in CADASIL vessels (Figure 2, E–G).
VSMC phenotype is altered in CADASIL. In order to further investigate the mechanisms underlying the 
vascular changes observed in CADASIL small arteries, primary culture VSMCs obtained from CADASIL 
vessels were studied. CADASIL VSMCs exhibited increased rates of  cell growth, as measured by carboxy-
fluorescein succinimidyl ester (CSFE) and flow cytometry (Supplemental Figure 2, A and B) and by the 
increased expression of  proliferating cell nuclear antigen (PCNA), a marker of  cell proliferation (Supplemen-
tal Figure 2C). Caspase 3/7 activity, a molecular index of  apoptosis, was also elevated in CADASIL VSMCs 
compared with controls (Supplemental Figure 1D). Phalloidin staining showed marked alteration of  actin 
cytoskeletal fibers in CADASIL VSMCs (Supplemental Figure 3). Together, these data suggest a proliferative 
and proapoptotic profile with cytoskeleton disorganization in CADASIL VSMCs.
Figure 1. Reduced vasodilation and vasoreactivity in CADASIL arteries. Assessment of vascular functional respons-
es in small arteries obtained from CADASIL and control subjects by wire myography. (A) Endothelium-dependent 
vasorelaxation in response to acetylcholine (ACh) and (B) endothelium-independent vasorelaxation in response to the 
nitric oxide (NO) donor, sodium nitroprusside (SNP), were decreased in CADASIL vessels (n = 6–17; two-way ANOVA 
with Bonferroni’s post hoc test). (C) The impairment in ACh-induced vasodilatation observed in CADASIL was slightly 
ameliorated in vessels pretreated with the ROS scavenger N-acetyl cysteine (NAC). (D) Maximum contractile responses 
(Emax) to phenylephrine (Phe) were also decreased in CADASIL vessels (n = 7–17; Student’s t test). Data are presented 
as mean ± SEM. *P < 0.05 versus control.
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Increased NOTCH3 signaling in CADASIL VSMCs. To evaluate whether NOTCH3 mutation is asso-
ciated with impaired Notch3 function and signaling, we assessed Notch3 receptor and Notch3 ECD 
(Notch3ECD) levels as well as NOTCH3-downstream gene targets in VSMCs from control and CADASIL 
patients. CADASIL VSMCs exhibited increased Notch3ECD accumulation (Figure 3A). Protein levels 
of  Notch3 transmembrane/cytosolic fragment (TMIC) and NOTCH3 receptor gene expression were 
increased in CADASIL VSMCs relative to controls (Figure 3, B and C). Following receptor cleavage, 
the Notch3 ICD (Notch3ICD) translocates to the nucleus, where it activates the transcription of  Notch 
target genes, including hairy/enhancer-of-split related with YRPW motif–like protein (HEYL), nuclear 
Figure 2. Vascular remodeling and 
altered mechanical properties 
in CADASIL arteries. Vascular 
structure and mechanical proper-
ties were assessed in pressurized 
small arteries obtained from 
CADASIL and control subjects. 
(A) External lumen diameter. (B) 
Lumen diameter. (C) Wall (media) 
thickness. (D) Media/lumen ratio. 
(E) Circumferential wall stress and 
(F) circumferential wall at increas-
ing intraluminal pressure (10–120 
mmHg) in calcium-free conditions. 
(G) Vascular stress-strain curve 
(n = 7–9; two-way ANOVA with 
Bonferroni’s post hoc test). Results 
are presented as mean ± SEM. *P < 
0.05 versus control.
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Figure 3. Mutant NOTCH3 gain of func-
tion in CADASIL VSMCs. (A) Represen-
tative immunofluorescence image of 
Notch3ECD in CADASIL and control VSMCs 
were stained with anti–α smooth muscle 
actin (α-SMA) and anti-Notch3ECD anti-
bodies. Objective: ×40. Scale bars: 20 μm. 
Corresponding bar graphs represent the 
fluorescence intensity of at least 5 images 
from 3 control and 3 CADASIL patients. 
(B) Expression of Notch3 transmembrane/
cytosolic fragment (TMIC). Upper panel: 
Representative immunoblot. Lower panel: 
Quantification of Notch3 TMIC protein 
levels. Protein expression was normalized 
to β-actin (n = 7–8; Student’s t test). (C) 
NOTCH3 gene expression and expression 
of NOTCH3 target genes (D) HEYL, (E) 
Nrip2, and (F) Grip2 in CADASIL and con-
trol VSMCs in the absence and presence 
of a γ-secretase inhibitor (GSI). Analysis 
was by qPCR and gene expression was 
normalized to GAPDH (n = 5–8; two-way 
ANOVA with Bonferroni’s post hoc test). 
Results are expressed as mean ± SEM. *P 
< 0.05 versus vehicle control; #P < 0.05 
versus vehicle plus CADASIL.
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Figure 4. Increased RhoA/Rho kinase activity and blunted [Ca2+]i transients in CADASIL VSMCs. (A) VSMC Rho 
kinase activity assessed by ELISA (n = 4–5; Student’s t test). (B and C) Expression of ROCK2 (B) and ROCK1 (C) in 
CADASIL and control VSMCs in the absence and presence of a γ-secretase inhibitor (GSI). Upper panels: Represen-
tative immunoblots. Lower panels: Quantification of ROCK2 and ROCK1 protein expression normalized to α-tubu-
lin (n = 6–10; two-way ANOVA with Bonferroni’s post hoc test). (D) Calcium transients were measured by live cell 
fluorescence imaging using the fluoroprobe Cal-520 AM. Representative tracings of VSMC [Ca2+]i responses to Ang 
II (1 × 10–7 mol/L) in CADASIL and control groups. Experiments were repeated 4 times/group with greater than 30 
cells studied/field. (E) [Ca2+]i calculated as the area under the curve. Arrow indicates time of Ang II stimulation (n 
= 4; Student’s t test). Results are expressed as mean ± SEM. *P < 0.05, **P < 0.01 versus control; #P < 0.05 versus 
vehicle plus CADASIL.
 
7insight.jci.org   https://doi.org/10.1172/jci.insight.131344
R E S E A R C H  A R T I C L E
receptor–interacting protein 2 (Nrip2), and glutamate receptor–interacting protein 2 (Grip2), which are 
involved in cell fate regulation. HEYL mRNA expression was increased in CADASIL VSMCs (Figure 
3D). Expression of  NOTCH3 and HEYL mRNA in CADASIL VSMCs was decreased to control levels 
when cells were pretreated with a γ-secretase inhibitor (GSI), which inhibits Notch3 activation (Figure 3, 
C and D). No significant changes were observed for Nrip2 and Grip2 mRNA levels (Figure 3, E and F).
Figure 5. Increased ER and oxidative stress 
in CADASIL VSMCs. ER stress–related genes 
were assessed by qPCR: (A) AMFR6, (B) 
EDEM1, (C) FBXO6, (D) MBTPS1, (E) VIMP, 
and (F) SYVN1. Results are normalized to 
GAPDH and expressed as mean ± SEM (n = 
4–9; Student’s t test). (G) Protein expression 
of binding immunoglobulin protein (BiP) (ER 
stress marker) in CADASIL and control VSMCs 
in the absence and presence of a γ-secretase 
inhibitor (GSI). Upper panel: Representative 
immunoblot of BiP. Lower panel: Quantifica-
tion of BiP protein expression, normalized to 
α-tubulin (n = 7; two-way ANOVA with Bonfer-
roni’s post hoc test). Results are expressed as 
mean ± SEM. *P < 0.05 versus vehicle control; 
#P < 0.05 versus vehicle plus CADASIL.
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Altered Ca2+ transients and augmented Rho kinase activity and ER stress in CADASIL. To investigate pos-
sible mechanisms that underlie the vascular functional abnormalities observed in CADASIL vessels, we 
measured changes in agonist-stimulated Ca2+ responses and activation of  the Rho kinase and ER stress 
pathways in VSMCs. As shown in Figure 4A, VSMC Rho kinase activity, as assessed by ELISA, was 
found to be increased in CADASIL VSMCs, relative to controls. This increased Rho kinase activity was 
associated with augmented protein expression of  the Rho-associated kinase Rho kinase 2 (ROCK2), which 
was abolished when Notch signaling was inhibited by a GSI (Figure 4B). Protein expression of  the other 
Rho-associated kinase, ROCK1, was unchanged (Figure 4C). Ca2+ transients were also altered in CADA-
SIL patient–derived VSMCs, in which the agonist-induced Ca2+ response was acute and not sustained, 
compared with control VSMCs (Figure 4, D and E). This difference in the Ca2+ transient was reflected by 
reduced area under the curve in the CADASIL group, likely indicating decreased cytosolic [Ca2+]i.
As shown in Figure 5, CADASIL patient VSMCs exhibited increased transcription of  ER stress genes: 
autocrine motility factor receptor (AMFR6), ER degradation enhancer mannosidase α–like 1 (EDEM1), 
F-box protein 6 (FBXO6), membrane-bound transcription factor (MBTPS1), VCP-interacting membrane 
protein (VIMP), and synoviolin 1 (SYVN1) (Figure 5, A–F). CADASIL VSMCs also showed an increase in 
protein expression of  BiP (Figure 5G), a molecular chaperone located in the ER and involved in ER pro-
tein handling. Increased BiP expression was reduced in CADASIL cells pretreated with the GSI. The ER 
stress response is typically associated with oxidative stress and, as shown in Figure 6, ROS production was 
significantly increased in CADASIL VSMCs compared with controls (Figure 6, B and C). Together, these 
Figure 6. Nox5-derived ROS is an upstream regulator of Rho kinase and ER stress in CADASIL VSMCs. (A) Expression of Nox5 in CADASIL and control 
VSMCs in the absence and presence of a γ-secretase inhibitor (GSI). Upper panels: Representative immunoblots. Lower panels: Quantification of Nox5 pro-
tein expression normalized to β-actin (n = 6–10; two-way ANOVA with Bonferroni’s post hoc test). (B) ROS production measured by lucigenin in CADASIL 
and control VSMCs in the absence and presence of a GSI, fasudil, and 4-PBA. Results are normalized by protein content (n = 6–8; two-way ANOVA with 
Bonferroni’s post hoc test). (C) Lucigenin in CADASIL and control VSMCs in the absence and presence of a Nox5 inhibitor (mellitin). Results are normalized 
by protein content (n = 6; two-way ANOVA with Bonferroni’s post hoc test). (D) Expression of BiP in CADASIL and control VSMCs in the absence and pres-
ence of mellitin. Upper panels: Representative immunoblots. Lower panels: Quantification of BiP protein expression normalized to β-actin (n = 7; two-way 
ANOVA with Bonferroni’s post hoc test). Results are expressed as mean ± SEM. *P < 0.05 versus vehicle control; #P < 0.05 versus vehicle plus CADASIL.
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data indicate that NOTCH3 mutations in CADASIL VSMCs manifest as a gain of  function and increased 
activation of  Notch3, with associated upregulation of  Rho kinase, ER stress responses, and oxidative stress.
Nox5-derived ROS is an upstream regulator of  Rho kinase and ER stress in CADASIL VSMCs. Both Rho 
kinase activation and ER stress are redox-sensitive processes. Accordingly, we investigated whether ROS 
play a role in Rho kinase activation and the ER stress response in CADASIL VSMCs. As demonstrated 
in Figure 6A, expression of  the major vascular Nox-producing oxidase in humans, NADPH oxidase 5 
(Nox5), is increased in CADASIL. This was associated with significantly increased ROS generation (Figure 
6, B and C), effects that were attenuated by GSI and mellitin (Figure 6, B and C), indicating that oxidative 
stress in CADASIL involves Notch3 and Nox5 and that Nox5 is downstream of  Notch3. The increase in 
BiP expression observed in CADASIL VSMCs was also inhibited by mellitin (Figure 6D), suggesting that 
the ER stress observed in CADASIL is associated with Nox5.
Interplay between NOTCH3, Rho kinase, and ER stress. To investigate potential interactions between Rho kinase 
and ER stress in CADASIL, we incubated VSMCs obtained from CADASIL patients and control subjects with 
Figure 7. Interplay between Notch3, ER 
stress, and Rho kinase in CADASIL VSMCs. 
(A–D) Pretreatment of VSMCs with 4-PBA (1 × 
10–3 mol/L) or fasudil (1 × 10–5 mol/L) reduced 
expression of (A) HEYL and (B) HES5, and 
ER stress–related genes (C) AMFR6 and (D) 
EDEM1 in CADASIL VSMCs without effect on 
control VSMCs (n = 3–14; one-way ANOVA 
with Bonferroni’s post hoc test). (E) Increased 
expression of BiP in CADASIL VMSCs was 
reduced in 4-PBA (1 × 10–3 mol/L) and fasudil 
(1 × 10–5 mol/L) pretreated cells. Upper panel: 
Representative immunoblot of BiP. BiP expres-
sion was normalized to β-actin (n = 4–10; 
one-way ANOVA with Bonferroni’s post hoc 
test). (F) 4-PBA decreased Rho kinase activity 
in CADASIL VMSCs, as assessed by ELISA (n = 
4–12; one-way ANOVA with Bonferroni’s post 
hoc test). Results are expressed as mean ± 
SEM. *P < 0.05, **P < 0.005 versus vehicle 
group from control VSMCs.
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4-phenylbutyric acid (4-PBA, ER stress inhibitor) or with fasudil (Rho kinase inhibitor). Both 4-PBA and fasudil 
reduced expression of NOTCH3 target genes HEYL (Figure 7A) and HES5 (Figure 7B) in CADASIL VSMCs, an 
effect that was absent in control VSMCs. 4-PBA and fasudil also reduced expression of the ER stress markers, 
AMFR6 (Figure 7C) and EDEM1 (Figure 7D) in CADASIL, with no effect observed on control VSMCs. Treat-
ing CADASIL VSMCs with 4-PBA also significantly reduced levels of BiP (Figure 7E), and activity of Rho 
kinase (Figure 7F). 4-PBA did not significantly alter Ca2+ transients (Supplemental Figure 4).
Rho kinase, ER stress, and VSMC function. To determine whether the Notch3/Rho kinase/ER stress net-
work contributes to the altered VSMC phenotype in CADASIL, we assessed effects of  4-PBA and fasudil 
on VSMC proliferation, apoptosis, and cytoskeletal regulation. Incubating CADASIL VSMCs with 4-PBA 
and fasudil did not influence their proliferation or apoptosis (Supplemental Figure 5, A and B) but ame-
liorated activation of  cytoskeletal regulatory proteins. Specifically, increased phosphorylation of  vimentin 
and cofilin in CADASIL VSMCs was normalized by 4-PBA and fasudil (Figure 8, A and B). In contrast, 
phosphorylation of  filamin, another actin-binding protein, was not altered in CADASIL cells, and 4-PBA 
and fasudil had no effect on its expression or phosphorylation (Figure 8C). These data suggest that ER 
Figure 8. ER stress inhibition and Rho kinase activity ameliorate VSMC cytoskeletal regulation in CADASIL. (A–C) 
Phosphorylation of cytoskeleton-associated proteins vimentin (A), cofilin (B), and filamin (C) was assessed by Western 
blotting in CADASIL and control VSMCs in the absence and presence of 4-PBA (1 × 10–3 mol/L) and fasudil (1 × 10–5 
mol/L). Representative Western blots show phosphorylated forms of vimentin, cofilin, and filamin. Expression levels 
of phosphorylated vimentin and filamin were normalized to total vimentin and filamin, while phosphorylated cofilin 
was normalized to β-actin. Results are expressed as mean ± SEM (n = 4–7; one-way ANOVA with Bonferroni’s post hoc 
test). *P < 0.05, **P < 0.005 versus control counterpart.
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stress and Rho kinase play an important role in VSMC cytoskeletal regulation, without significantly influ-
encing cell growth in CADASIL.
Altered function of  mesenteric arteries in TgNotch3R169C mice. TgNotch3R169C mice were used as an experimental 
model to further dissect molecular pathways identified in CADASIL patients. As shown in Supplemental 
Table 3, body weight and systolic blood pressure (SBP) of  TgNotch3R169C mice were similar to wild-type 
(TgNotch3WT) controls. Cardiac function and structure were similar between groups, with no differences in 
Figure 9. Vascular function and arterial 
remodeling in CADASIL mice. Assessment 
of vascular functional responses in mes-
enteric arteries from TgNotch3WT (TgN3WT) 
and TgNotch3R169C (TgN3R169C) mice by wire 
myography. (A) Endothelium-independent 
vasorelaxation in response to sodium 
nitroprusside (SNP). (B) Vasorelaxation in 
response to SNP in the presence of fasudil 
(1 × 10–6 mol/L; 30 minutes), and (C) 4-PBA 
(1 × 10–3 mol/L; 30 minutes) (2-way ANOVA 
with Bonferroni’s post hoc test). Vascular 
structure was assessed in pressurized 
mesenteric arteries from TgNotch3WT and 
TgNotch3R169C mice. (D) External lumen 
diameter. (E) Lumen diameter. (F) Wall 
thickness. (G) Media/lumen ratio. (H) 
Cross-sectional area (CSA) at increasing 
intraluminal pressure (10–120 mmHg) 
in calcium-free conditions. Results are 
presented as mean ± SEM (n = 6; one-way 
ANOVA with Bonferroni’s post hoc test). 
*P < 0.05 versus TgNotch3WT; †P < 0.05 
versus TgNotch3R169C.
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heart weight, fractional shortening (FS), mitral valve E/A (ratio of  early [E] and late [atrial; A] ventricular 
filling velocity), and anterior wall thickness between TgNotch3R169C and control mice (Supplemental Table 3).
We next assessed vascular function in small resistance arteries of TgNotch3WT and TgNotch3R169C mice using 
wire myography. Similar to what we observed in CADASIL patients, vessels from TgNotch3R169C mice showed 
significant reduction in SNP-induced vasorelaxation (Figure 9A) compared with responses in TgNotch3WT mice. 
Figure 10. NOTCH3 signaling in mutant 
TgNotch3R169C mice. (A) Upper panel: Rep-
resentative immunoblot of the NOTCH3 
transmembrane/cytosolic (TMIC) frag-
ment in aortas from TgNotch3WT (TgN3WT) 
and TgNotch3R169C (TgN3R169C) mice. Lower 
panel: Quantification of NOTCH3 TMIC 
protein levels. Protein expression was 
normalized to β-actin (n = 6; Student’s 
t test). (B–G) NOTCH3 gene expression 
and expression of NOTCH3 target genes 
HEYL and Hes5 in FVB, TgNotch3WT, and 
TgNotch3R169C aortas (B, D, and F) and mes-
enteric arteries (C, E, and G), as assessed 
by qPCR. Gene expression was normalized 
to GAPDH (n = 5–8; one-way ANOVA 
with Tukey’s post hoc test). Results are 
expressed as mean ± SEM. *P < 0.05 ver-
sus TgNotch3WT; ∞P < 0.05 versus FVB.
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These responses were restored when arteries were exposed to fasudil (Figure 9B) and 4-PBA (Figure 9C). No 
changes were observed in vessels from TgNotch3WT mice incubated with fasudil and 4-PBA. We also investi-
gated vascular structure by pressure myography. The external and internal diameters, cross-sectional area, wall 
thickness, and the media/lumen ratio of vessels in TgNotch3R169C mice were similar to those in TgNotch3WT 
vessels (Figure 9, D–H).
Increased Notch3 signaling, Rho kinase and ER stress–related protein expression in TgNotch3R169C mice. 
Expression of  Notch3 TMIC was increased in TgNotch3R169C vessels compared with TgNotch3WT con-
trols (Figure 10A). Notch3 mRNA expression was also increased in the aorta and mesenteric arteries 
from TgNotch3R169C mice compared with control wild-type mice (Figure 10, B and C, respectively). 
Transcription of  the downstream Notch3 target gene Heyl was increased in both the aorta (Figure 10D) 
and mesenteric arteries (Figure 10E) from TgNotch3R169C mice compared with controls, while Hes5 gene 
expression was unchanged in TgNotch3R169C mice (Figure 10, F and G). As shown in Figure 11, A and D, 
respectively, vascular expression of  BiP and the Rho guanine nucleotide–exchange factor (GEF), p115, 
was increased in TgNotch3R169C mice compared with TgNotch3WT. Gene expression of  Larg and Pdz was 
unchanged in TgNotch3R169C mice (Figure 11, B and C).
Discussion
Molecular processes underlying the vasculopathy in CADASIL are elusive. To address this, we investigated 
disease-appropriate human tissue from clinically phenotyped CADASIL patients and interrogated mecha-
nisms at the molecular, cellular, and vascular levels. Major findings from our study show that small arteries 
Figure 11. Increased vascular expression of ER stress– and Rho kinase–related proteins in CADASIL mice. (A) BiP protein 
levels were assessed by immunoblotting using aortas from TgNotch3WT (TgN3WT) and TgNotch3R169C (TgN3R169C) mice. Results 
are normalized to β-actin and are expressed as mean ± SEM (n = 5; Student’s t test). The same β-actin loading control was 
used in both A and Figure 10A since the same membrane was reprobed for β-actin, NOTCH3 TMIC, and BiP. (B–D) mRNA 
expression of the Rho GEFs PDZ (B), LARG (C), and p115 (D) in TgNotch3WT and TgNotch3R169C mice (n = 6–7; Student’s t test). 
Gene expression is normalized to GAPDH. Results are expressed as mean ± SEM. *P < 0.05 versus TgNotch3WT. 
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in CADASIL exhibit functional and structural alterations defined by reduced vasoreactivity, hypertrophic 
remodeling, and decreased stiffness, processes linked to increased VSMC proliferation and apoptosis and 
cytoskeletal reorganization. At the molecular level, vascular abnormalities in CADASIL were associated 
with Notch3 gain of  function, Nox5-induced oxidative stress, ER stress response, and Rho kinase activa-
tion. Perturbed signaling and activation of  cytoskeleton-associated proteins in CADASIL were ameliorated 
by 4-PBA and fasudil, highlighting a role for ER stress and Rho kinase in the vasculopathy of  CADA-
SIL. These phenomena in human studies were recapitulated and further interrogated in TgNotch3R169C 
mice, where vascular dysfunction was normalized by inhibitors of  4-PBA and fasudil. Our findings iden-
tify important interplay between Notch3, ER stress, and Rho kinase, in part through Nox5-derived ROS, 
that underlie small-vessel injury and dysfunction in CADASIL. These candidates may be potential mecha-
nism-specific druggable targets in the disease.
We provide direct evidence that CADASIL-causing NOTCH3 mutations have vascular manifestations 
beyond the cerebral vasculature and that peripheral small arteries are abnormal in CADASIL. Function-
ally, vasorelaxation was reduced and agonist-induced vasoconstriction was attenuated in CADASIL. 
VSMC contraction and relaxation are characteristically regulated by increased [Ca2+]i, which triggers 
contraction (38). Our findings of  reduced agonist-stimulated Ca2+ transients indicate perturbed contrac-
tile signaling in CADASIL VSMCs. Mechanisms whereby mutant Notch3 influences these processes are 
unclear, but alterations in Ca2+ influx and efflux may be important since Notch3 regulates Ca2+ channels 
(store-operated Ca2+ entry, canonical transient receptor potential [TRPC6]) (39). Structurally, CADASIL 
arteries exhibited hypertrophic remodeling (increased media/lumen ratio) with reduced stiffness possi-
bly due to cytoskeletal reorganization and dysregulated cell growth. Increased apoptosis was associated 
with VSMC growth in CADASIL and may represent attempts to counteract excessive proliferation and 
vascular remodeling. On the other hand, VSMC proliferation may be a response to cell death and apop-
tosis. Changes in the fine-tuning of  cell growth and apoptosis probably contribute to structural vascular 
remodeling in CADASIL. Alteration in the VSMC phenotype in CADASIL may also be a direct effect of  
Notch3 activation because Notch3 plays an important role in phenotypic switch-type behavior of  vascu-
lar cells, as demonstrated by a computational framework of  Notch signaling (40). Confirming activation 
of  Notch3 signaling in CADASIL cells was increased expression of  NOTCH3 targets, HeyL and Hes, 
effects that were attenuated by γ-secretase inhibition.
Our findings of  reduced vasoreactivity in peripheral arteries support our previous studies in cere-
bral arteries in CADASIL (15). Others have also reported decreased cerebrovasodilation in CADASIL 
patients challenged with CO2 and acetazolamide (41). These vascular abnormalities likely contribute to 
brain hypoperfusion injury and to the consequent stroke and dementia that characterize CADASIL. How-
ever, it remains unclear why CADASIL is not associated with systemic vascular disease (42), especially 
in light of  the significant vascular dysfunction and arterial remodeling in the peripheral circulation, as we 
demonstrate here. It might be that systemic vasoprotective mechanisms, involving the sympathetic ner-
vous system, differentially influence cerebral and peripheral arteries. It may also be possible that reduced 
vasoconstriction counteracts impaired vasodilation in an attempt to maintain vascular tone. This awaits 
confirmation, as yet undefined mechanisms are also likely to be important. CADASIL is typically a dis-
ease of  small vessels, and in line with previous studies, vascular function of  large arteries, as assessed by 
pulse wave velocity, was not altered in CADASIL patients in our study.
Experimental models of  human disease, specifically TgNotch3R169C mice that recapitulate salient prop-
erties of  CADASIL, including cerebrovascular structural alterations, reduced vasodilation, and diminished 
pressure-induced vasoconstriction (6), have been used to dissect underlying mechanisms. Pathophysiologi-
cal processes associated with cerebrovascular dysfunction in TgNotch3R169C mice include a Kv1 channelop-
athy and increased levels of  extracellular matrix proteins, including TIMP3 (6, 16–18, 43). These processes 
have not been demonstrated in human disease. Molecular systems that have been implicated in CADASIL 
patients include decreased TRPV1 channel expression, altered PDGF signaling, and oxidative stress (20–
24). However, these studies were performed in human cell lines from the umbilical cord, skin fibroblasts, 
and induced pluripotent stem cells, which have little relevance in the vasculopathy of  CADASIL (19–22).
In a proteomic screen in VSMCs from a CADASIL patient, expression of  proteins involved in protein 
degradation/folding, cytoskeletal organization, contraction, and cell stress was increased (19). Many of  these 
processes are associated with ER stress, which has also been demonstrated in CADASIL cells (23, 24) and in 
vascular dysfunction associated with hypertension (44) and diabetes (45). In our study, expression of  ER stress 
1 5insight.jci.org   https://doi.org/10.1172/jci.insight.131344
R E S E A R C H  A R T I C L E
genes, namely AMFR6, EDEM1, FBXO6, MBTPS1, VIMP, and SYVN was increased in CADASIL VSMCs. 
In addition, VSMC expression of  BiP, a chaperone molecule involved in the ER unfolded protein response 
was increased in CADASIL patients, a phenotype that was recapitulated in TgNotch3R169C mice. AMFR6, 
EDEM1, and FBXO6 participate in protein degradation, while MBTPS1, VIMP, and SYVN1 play a role in 
protein removal (46). Associated with ER stress in CADASIL VSMCs was upregulation of  Rho kinase, which 
itself  has been shown to influence ER stress (30). RhoA/Rho kinase signaling influences VSMC contraction, 
growth, and cytoskeletal organization and is an important regulator of  Ca2+-independent vasocontraction and 
endothelium-independent vasorelaxation, processes that were impaired in CADASIL VSMCs. Increased Rho 
kinase activity has been demonstrated in models of  vascular dysfunction (47, 48) and has been suggested as a 
therapeutic target in cerebral vascular disorders in patients with ischemic stroke and cerebrovascular disorders 
(49, 50). We advance this notion and suggest that Rho kinase plays a role in VSMC dysfunction in CADA-
SIL. This is supported by studies showing that Notch3 is an upstream regulator of  RhoA/Rho kinase and is 
involved in resistance artery mechanotransduction and pressure-induced (myogenic) tone (33, 51).
Pharmacological inhibition of  Notch activation with GSI decreased expression of  BiP and Rho kinase, 
confirming that Notch3 is an upstream regulator. The functional significance of  these systems was further 
explored using 4-PBA and fasudil, which corrected many of  the abnormal molecular changes in CADASIL 
VSMCs, including Notch3 downstream target genes, Rho kinase activity, and ER stress markers. In addi-
tion, in CADASIL VSMCs, 4-PBA and fasudil normalized increased phosphorylation of  cytoskeleton-as-
sociated proteins, vinculin and cofilin, which are structural proteins that influence cytoskeletal organiza-
tion. These inhibitors had no effect on VSMC proliferation or apoptosis but ameliorated the cytoskeletal 
remodeling defects in CADASIL, indicating that ER stress– and Rho kinase–mediated functional respons-
es are not generalized phenomena, but are highly specific. Of  significance, 4-PBA reduced Rho kinase 
activity, while fasudil decreased BiP expression, indicating crosstalk between ER stress and Rho kinase 
in the context of  increased Notch3 activity in CADASIL. Interactions between these pathways have been 
reported in other systems, as evidenced by (i) reduction in renal Notch signaling in response to Rho kinase 
inhibition (52), (ii) Notch3-induced activation of  Rho kinase in pluripotent stem cells (51), (iii) decreased 
vascular Rho A signaling in Notch3-deficient mice (33), (iv) amelioration of  ER stress by Rho kinase inhib-
itors (30), and (v) Notch3 association with ER stress (32).
We further explored putative upstream systems regulating vascular signaling in CADASIL, focusing 
on oxidative stress, since Rho kinase and ER stress response are highly redox sensitive. Similar to what has 
been demonstrated previously in other small vessel diseases of  the brain (53–56), we found increased ROS 
production in CADASIL VSMCs. Moreover, we identified Nox5, the major Nox isoform responsible for 
vascular ROS generation in humans, as a key source of  vascular oxidative stress in CADASIL. Hence, we 
define what we believe is a novel system whereby mutant Notch3 activation induces Nox5-derived ROS 
generation that influences ER stress response and vascular function in human CADASIL. Mechanisms 
whereby Notch3 regulates Nox5 expression/activity are unclear but may relate to increased activation of  
Notch3-regulated transcription factors, which could influence Nox5 processing.
To further support the notion that Rho kinase and ER stress directly influence vascular dysfunction in 
CADASIL and as a proof of  concept, we performed vascular functional studies in our preclinical mouse 
model of  CADASIL and showed that both fasudil and 4-PBA ameliorate impaired vasorelaxation. The exper-
imental model was studied to facilitate easy access of  sufficient vascular tissue, which is a limitation in human 
studies. Whether similar effects observed in CADASIL mice also occur in intact vessels from CADASIL 
patients awaits confirmation, but our molecular studies in human CADASIL VSMCs are certainly supportive.
In conclusion, we demonstrate that peripheral small arteries from CADASIL patients exhibit endothe-
lial dysfunction, impaired endothelium-independent vasorelaxation, hyporeactivity, and altered structural 
and mechanical properties, processes associated with altered VSMC growth and cytoskeletal reorganiza-
tion and perturbed vascular signaling involving Notch3 gain of  function, Nox5-derived ROS, ER stress, 
and Rho kinase activation. Using a reverse translational approach, observations in CADASIL patients were 
recapitulated in TgNotch3R169C mice. Our findings identify a Notch3-regulated pathway involving interplay 
between the ER stress response and Rho kinase in the vasculopathy of  CADASIL. Inhibiting ER stress and 
Rho kinase with FDA-approved pharmacological agents, 4-PBA and fasudil, ameliorated vascular dysfunc-
tion in CADASIL, highlighting these pathways as potentially beneficial therapeutic targets. Our study also 
shows that vascular alterations in CADASIL manifest peripherally and are not only confined to the cerebral 
vasculature, suggesting that peripheral artery responses may be an accessible biomarker in CADASIL.
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Methods
Subject recruitment. Patients with genetically and clinically confirmed CADASIL (n = 20) were recruited 
from the Neurovascular Genetics clinic, Queen Elizabeth University Hospital, Glasgow. Healthy controls 
were volunteers at the Ottawa Hospital Research Institute (n = 11). Under local anaesthetic, all subjects 
underwent a gluteal biopsy from which intact small arteries (<200 μm diameter) were dissected from sub-
cutaneous fat. These arteries were used for functional, structural, and mechanical studies by wire and pres-
sure myography, and VSMCs were isolated for primary cell culture, as previously described (35, 57) and 
summarized below. Identical protocols were used for CADASIL patients and control studies.
Pulse wave analysis in CADASIL patients. Pulse wave analysis was performed as an assessment of  large 
vessel arterial stiffness using the Sphygmocor system, as previously described (15). Values were compared 
to published normal values for healthy control individuals (34).
Mouse model of  CADASIL. The transgenic (Tg) mouse lines, TgNotch3WT and TgNotch3R169C, have been 
previously characterized and described (6). Briefly, TgNotch3WT and TgNotch3R169C mice (on an FVB back-
ground) express rat wild-type Notch3 and the CADASIL-causing Notch3(R169C) mutant protein, respec-
tively, to a similar degree (approximately 4-fold) compared with levels of  endogenous Notch3 in nontrans-
genic mice (6). Mice were housed in individual cages in a room with controlled humidity and temperature 
(22°C–24°C), and in light/dark cycles of  12 hours with free access to food and tap water. They were studied 
at 6 months of  age, at which stage features of  CADASIL are well established, as previously described (6, 
16, 17, 58, 59). Mice were sacrificed at 6 months of  age (at which age they exhibit features of  the human 
disease), and blood and tissue were collected for experiments. Small mesenteric arteries were used to assess 
vascular function, structure, and mechanics by wire and pressure myography. The aorta and mesenteric 
arteries were used to investigate Notch3 signaling and ER stress markers.
Blood pressure measurement and echocardiography in mice. SBP was assessed by tail-cuff  plethysmogra-
phy (60). Mice were trained to the apparatus (Visitech Systems model BP-2000) for 2 consecutive weeks 
until stable readings were obtained. SBP measurements were assessed on the week prior to the start of  
the experimental protocols.
Cardiac function and structure were assessed by echocardiography using an Acuson Sequoia c512 
ultrasound system to acquire noninvasive 2D guided M-mode images at a 20 mm depth at the tip of  
the papillary muscles. Measurements were made in a short axis view using the leading edge-to-lead 
edge convention during both systole and diastole over at least 3 consecutive cardiac cycles. Echocardio-
graphic indices assessed included left ventricular anterior wall thickness (LVAW), LV end-diastolic vol-
ume (LVEDV), LV end-systolic volume (LVESV), LV end-diastolic diameter (LVEDD), LV end-systolic 
diameter (LVESD), and FS to assess LV systolic function. Early (E) and late (atrial; A) ventricular filling 
velocity were calculated from measuring blood velocities across the mitral valve during each cardiac 
cycle. E/A ratio was calculated as an indirect measure of  diastolic function. Ejection fraction (EF) = 
([LVEDV – LVESV]/LVESD × 100); FS = ([LVEDD – LVESD]/LVEDD × 100).
Human and mouse vascular functional studies. Gluteal biopsies of  subcutaneous fat measuring approximately 
2 cm × 1 cm × 1 cm were obtained under local anaesthetic. Small arteries were dissected from gluteal fat and 
cut into 2-mm ring segments (34, 57). Small arteries were also dissected from mesenteric arteries isolated from 
TgNotch3WT and TgNotch3R169C mice, as previously described (57). Briefly, arterial segments were mounted 
on isometric wire myographs (Danish Myo Technology) filled with 5 mL of physiological saline solution (in 
mmol/L: 130 NaCl, 14.9 NaHCO3, 4.7 KCl, 1.18 KH2PO4, 1.17 MgSO4•7H2O, 5.5 glucose, 1.56 CaCl2•2H2O, 
and 0.026 EDTA) and continuously gassed with a mixture of  95% O2 and 5% CO2 while being maintained at 
a constant temperature of  37°C ± 0.5°C. Following 60 minutes of  equilibration, the contractile responses of  
arterial segments were assessed by the addition of  KCl (62.5 mmol/L). The integrity of  the endothelium was 
verified by relaxation induced by Ach (1 × 10–5 mol/L) in arteries precontracted with PE (1 × 10–6 mol/L). 
Endothelium-dependent relaxation was assessed as a dose response to Ach (1 × 10–9 to 3 × 10–5 mol/L) in 
human vessels. Endothelium-independent vasorelaxation was assessed by a dose response to SNP (1 × 10–9 to 
10–5 mol/L) in human vessels. Phenylephrine and Ang II (1 × 10–9 to 3 × 10–5 mol/L) concentration-response 
curves were generated to evaluate vasoconstriction in human arteries (60).
TgNotch3WT and TgNotch3R169C mouse vascular responses to SNP were performed in mesenteric 
arteries precontracted with U46619 (3 × 10–8 mol/L). Vascular functional responses to SNP were 
also assessed in the absence and presence of  4-PBA (1 × 10–3 mol/L, 30 minutes) or fasudil (1 × 10–6 
mol/L, 30 minutes).
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Vascular structure and mechanical properties in human and mouse small arteries. Additional arterial segments 
(~4 mm long) from CADASIL patients and control subjects and TgNotch3WT and TgNotch3R169C mice 
were studied as pressurized preparations using a Pressure Myograph System (110P system; Danish Myo 
Technology) in Ca2+-free physiological saline solution where intramural pressure was set to 70 mmHg 
for 30 minutes to allow vessels to equilibrate and to generate a variable degree of  myogenic tone. Vessels 
were subjected to an increasing intramural pressure gradient, ranging from 10 to 120 mmHg at 5-minute 
intervals. Internal and external vessel wall measurements were recorded and used to calculate structural 
and mechanical properties, as previously described (26, 60). Briefly, from internal (Di) and external (De) 
diameter measurements in passive conditions, the following structural parameters were calculated: wall 
thickness (WT) = (De – Di)/2; media/lumen ratio = (De – Di)/2D; circumferential wall strain = (Di – Do)/
Do, where Do is the internal diameter at 10 mmHg and Di is the observed internal diameter for a given 
intravascular pressure, both measured in Ca2+-free physiological saline solution; circumferential wall stress 
= (P × Di)/(2WT), where P is the intraluminal pressure (1 mmHg = 1.334 × 10
3 dynes/cm2) and WT is 
measured at each intraluminal pressure in Ca2+-free physiological saline solution.
Human VSMC isolation. Methods for the isolation and culture of human VSMCs have been previously 
described (57). Briefly, cleaned arteries were placed in Ham’s F-12 culture medium containing 1% gentamicin, 
collagenase (type 1), elastase, soybean trypsin inhibitor, and BSA, and were incubated for 1 hour at 37°C under 
constant agitation. The digested tissue was further dissociated by repeated aspiration through a syringe with a 
20-gauge needle. The cell suspension was centrifuged (2000 rpm, 4 minutes) and the cell pellet was resuspended 
in Ham’s F-12 culture medium containing 10% FBS. Cells were seeded onto 25-mm round glass coverslips. For 
the first 48 hours, cells were incubated in Ham’s F-12 culture medium containing 10% heat-inactivated fetal 
calf  serum. Thereafter, VSMCs were maintained in Medium 231 containing Smooth Muscle Growth Sup-
plement (SMGS) (both Thermo Fisher Scientific) with penicillin/streptomycin. Before experimentation, cells 
were rendered quiescent by maintenance in a reduced-growth-supplement medium (0.5% FBS) for 18 hours. 
Only primary, low-passage cells (passages 2 to 6) were studied. In some protocols, the role of ER stress, Rho 
kinase, and Notch signaling was assessed using pharmacological inhibitors: ER stress inhibitor, 4-PBA (1 × 10–3 
mol/L, Sigma-Aldrich); Rho kinase inhibitor, fasudil (1 × 10–5 mol/L, Tocris); and Notch inhibitor, GSI XXIII 
(5 μmol/L, Calbiochem, 565792). Cells were preexposed to 4-PBA, fasudil, or GSI for 24 hours.
Cell proliferation. The fluorescein-based dye 5,6-carboxyfluorescein diacetate succinimidyl ester (CFSE) 
(CellTrace, Thermo Fisher Scientific) was used to assess proliferation of  cultured VSMCs. CSFE is a fluores-
cent cell-staining dye used to monitor cell proliferation due to the progressive halving of  CFSE fluorescence 
within daughter cells following each cell division. VSMCs were detached from culture plates using 0.04% 
Trypsin/0.03% EDTA (PromoCell GmbH, Germany) and were then incubated with 5 × 10–6 mol/L CFSE 
in 1 mL of  PBS for 30 minutes at 37°C. Cells were then resuspended in complete Medium 231 and washed 
twice. CFSE-labeled VSMCs were plated at 30% confluence and cultured for 4 days in Medium 231, supple-
mented with 50% SMGS. After this period, cells were detached from the plates with 0.04% Trypsin/0.03% 
EDTA and resuspended in 1% BSA in PBS. Flow cytometry analysis with Ex/Em 492 nm/517 nm filters 
was performed using the FACS CANTO II system (BD Biosciences), using acquisition FACS DIVA soft-
ware v6.1.3 (BD Biosciences). Data acquisition was analyzed using FlowJo X software (Tree Star).
Apoptosis assay. Apoptosis was assessed by caspase 3/7 activity measured using the Caspase-Glo 3/7 
Assay kit (Promega) according to the manufacturer’s instructions. Briefly, 1000 VSMCs/well were seeded 
into Pierce White Opaque 96-Well Microplates (Thermo Fisher Scientific) and cultured for 3 hours to allow 
cells to adhere. The cells were then washed with PBS and the medium replaced with 50 μL Opti-MEM and 
incubated for 24 hours. An equal volume of  the Caspase-Glo 3/7 substrate was added to each well of  the cell 
culture plate and mixed using a microplate vortex mixer at maximum setting for 5 minutes to ensure cells 
were lysed. The plate was then incubated at room temperature for 1 hour before reading cell luminescence.
Phalloidin staining. Cytoskeletal organization was assessed using phalloidin staining (Cytoskeleton) 
according to the manufacturer’s instructions. Briefly, VSMCs were fixed with 2% paraformaldehyde 
(PFA) in PBS at room temperature for 20 minutes, PFA was removed, cells were washed 3 times with 
PBS, and nonspecific binding sites were blocked with 1% FBS in PBS for 30 minutes at room tempera-
ture followed by incubation with phalloidin stain (1 × 10–7 mol/L) in 1% FBS in PBS for 30 minutes in a 
humidified chamber in the dark. Cells were then washed 3 times with PBS and mounted on glass slides 
using Prolong medium with DAPI (Thermo Fisher Scientific). Fluorescence imaging was performed using 
a Zeiss confocal imaging system (LSM500). DAPI was excited at 405 nm and phalloidin at 535 nm. 
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Images were acquired using Zen Pro (Zeiss). Each experimental group was imaged in duplicate with a 
minimum of  40 images being analyzed by 2 blinded observers using a previously described protocol (61) 
as follows: 1, “intact” filamentous structures in most cells (rare or no “damaged” fibrils); 2 (mild), more 
intact filamentous structure than damaged structures; 3 (moderate), more damaged structure than intact; 
and 4 (severe), predominantly damaged structures (few intact fibrils). Intact was defined as discernible, 
distinct, and organized filaments and damaged referred to disorganized, disarrayed, aggregated, clumped, 
or indiscernible structures.
Quantitative real-time polymerase chain reaction. Quantitative real-time polymerase chain reaction (qPCR) 
(Qiagen) was used to assess expression of  Notch3 target genes (Hes5 and HeyL) and ER stress genes (AMFR6, 
EDEM1, FBXO6, MBTPS1, VIMP, and SYVN1) in control and CADASIL VSMCs. mRNA expression of  
Notch3, Hes5, and HeyL was also measured by qPCR in the aorta and mesenteric arteries isolated from 
TgNotch3WT and TgNotch3R169C mice. The gene expression of  the Rho GEFs LARG, p115, and PDZ was 
also analyzed in the aorta from TgNotch3WT and TgNotch3R169C mice. For some experiments, wild-type 
FVB mice were used as a control for Notch3 and Notch3 target gene expression because TgNotch3WT and 
TgNotch3R169C mice were on the FVB background. Briefly, total RNA was extracted from tissues using TRIzol 
(Qiagen), treated with RNase-free DNAse I, and 2 μg of  RNA was reverse transcribed in a reaction contain-
ing 100 μg/mL oligo-dT, 10 mmol/L 2′-deoxynucleoside 5′-triphosphate, 5× First-Strand buffer, and 2 μL 
of  200-U reverse transcriptase. For real-time PCR amplification, 3 μL of  each reverse transcription product 
was diluted in a reaction buffer containing 5 μL of  SYBR Green PCR master mix and 300 nmol/L primers 
in a final volume of  10 μL per sample. The reaction conditions consisted of  2 steps at 50°C for 2 minutes and 
95°C for 2 minutes, followed by 40 cycles of  3 steps, 15-second denaturation at 95°C, 60-second annealing at 
60°C, and 15 seconds at 72°C. Mouse primers used are detailed in Supplemental Table 1. Data are expressed 
as target gene/GAPDH housekeeping gene. Relative gene expression was calculated by the 2ΔΔCt method, 
and the results reported as arbitrary units relative to the control conditions. RT2 primer sets (Qiagen) were 
used (proprietary primers, sequence not disclosed). Human GAPDH, Nrip2, and Grip2 primer sequences 
are as follows: Forward, GAGTCAACGGATTTGGTCGT; Reverse, TTGATTTTGGAGGGATCTCG; 
Forward, GTTCCTGCACAAGGACTCGG; Reverse, AGGCGTCTTTGGATCACACTG; and Forward, 
GCAGGGGAGACAATAGCGAAC; Reverse, CACAGTGATCCCTCGGAACT; respectively.
Measurement of  intracellular Ca2+ transients in VSMCs. VSMC Ca2+ signaling was assessed using the flu-
orescent Ca2+ indicator, Cal-520 acetoxymethyl ester (Cal-520 AM; Abcam; 5 × 10–6 mol/L). Cells were 
grown in 6-well plates and following removal of  culture media were incubated with 10–5 mol/L Cal-520 AM 
in 0.5% FBS at 37°C for 75 minutes followed by 30 minutes at room temperature. Following incubation, 
the dye solution was replaced with HEPES physiological saline solution (1.3 × 10–1 mol/L NaCl, 5 × 10–3 
mol/L KCl, 10–3 mol/L CaCl2, 1 × 10
–3 mol/L MgCl2, 2 × 10
–2 mol/L HEPES, and 1 × 10–2 mol/L D-glu-
cose, pH 7.4) for 30 minutes prior to imaging. VSMCs were stimulated with Ang II (1 × 10–7 mol/L) and the 
Ca2+ transient tracked for 5 minutes. In some experiments, VSMCs were pretreated for 24 hours with 4-PBA 
or fasudil. Fluorescence-based measurements of  Ca2+ signals were performed using the inverted epifluores-
cence microscope Axio Observer Z1 Live-Cell imaging system (Zeiss) with excitation/emission wavelengths 
490 nm and 525 nm, respectively. Images were acquired and analyzed using Zen Pro (Zeiss).
Immunoblotting. Protein was extracted from cultured human VSMCs and from vessels isolated from 
TgNotch3WT and TgNotch3R169C mice. Protein (30 μg) was separated by electrophoresis in a polyacrylamide 
gel and transferred to a nitrocellulose membrane. Nonspecific binding sites were blocked with 3% BSA in 
Tris-buffered saline (TBS) solution. Membranes were then incubated with specific antibodies overnight at 
4°C. Membranes were washed 3 times with TBS/Tween 20 and incubated with infrared dye–labeled second-
ary antibodies for 1 hour at room temperature. Membranes were visualized using an Odyssey CLx infrared 
imaging system (LiCor Biosciences) and results were normalized to β-actin protein and are expressed in arbi-
trary units. Antibodies used were as follows: anti-ROCK2 (1:500, 610623, BD Biosciences); anti-ROCK1 
(1:500; PIPA521130, Chemicon International); anti-PCNA (sc-56, Santa Cruz Biotechnology); anti-BiP 
(1:1000; 610978, BD Biosciences); anti-Notch3 (1:2000; 5276, Cell Signaling Technology); anti–β-actin 
(1:5000; A1978, Sigma-Aldrich); anti–α-tubulin (1:10000, ab4074, Abcam); anti–phospho-cofilin (3313S, Cell 
Signaling Technology); anti–phospho-vimentin (7391S, Cell Signaling Technology); anti-vimentin (3632S, 
Cell Signaling Technology); anti–phospho-filamin (4761S, Cell Signaling Technology); anti-filamin (4762S, 
Cell Signaling Technology); and anti-Nox5 (1: 1000; provided by David Harrison, Vanderbilt University Med-
ical Center, Nashville, Tennessee, USA) (61).
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Rho kinase activity. Rho kinase activity was measured with a Rho-associated Kinase Activity Assay kit 
(Merck, CSA001), according to the manufacturer’s instructions. Briefly, VSMCs cells were lysed and 50 
μL was placed in 96-well multistrip plates and incubated for 30 minutes at 30°C on an orbital shaker. Each 
microwell was washed 3 times with 1× wash buffer before an anti–phospho-MYPT1 (Thr696) antibody 
was added for 1 hour at room temperature. Wells were washed again, and a goat anti–rabbit IgG HRP 
secondary antibody added for 1 hour at room temperature, followed by a wash and the addition of  chromo-
genic substrate tetra-methylbenzidine (TMB) for 15 minutes. The reaction was stopped with Stop Solution 
and absorbance at 450 nm was measured spectrophotometrically. Rho kinase activity was normalized to 
protein content for each sample measured using the DC assay (Bio-Rad).
Immunofluorescence staining of  VSMCs. For immunofluorescence analysis, VSMCs were plated and 
grown on a microscope chamber slide (Ibidi). Cells were fixed in fresh 2% PFA for 20 minutes followed 
by washing with PBS. Nonspecific binding was blocked with 5% BSA in PBS for 1 hour at room tempera-
ture. Primary antibody incubation was performed overnight at 4°C with the following antibodies diluted 
in 0.2% BSA in PBS: mouse monoclonal anti-Notch3ECD (clone 1E4, 1:200, MABC594, Millipore) and 
rabbit polyclonal anti–α smooth muscle actin (1:200, ab5694, Abcam). For detection, Alexa Flour 488– and 
Alexa Flour 647–coupled secondary antibodies (Life Technologies) were diluted in 0.2% BSA in PBS and 
applied for 1 hour at room temperature. A mouse IgG1 negative control antibody (Serotec, MCA928) was 
also used. After washing, vessels were mounted with Fluoroshield mounting medium containing DAPI 
(Abcam, ab104139). Images were captured by confocal microscopy (LSM880, Zeiss) using a 40× objective. 
The fluorescence mean value was determined using ImageJ (version 1.60, NIH).
Lucigenin-enhanced chemiluminescence. Lucigenin-enhanced chemiluminescence assay was used to deter-
mine NADPH-dependent ROS production in control and CADASIL VSMCs, as we previously described 
(62). Cells were homogenized in lysis buffer (20 mmol/L KH2PO4, 1 mmol/L EGTA, 1 μg/mL aprotinin, 1 
μg/mL leupeptin, 1 μg/mL pepstatin, and 1 mmol/L PMSF). Fifty microliters of  the sample was added to 
a suspension containing 175 μL of assay buffer (50 mmol/L KH2PO4, 1 mmol/L EGTA, and 150 mmol/L 
sucrose) and lucigenin (5 μmol/L). Luminescence was measured with a luminometer (AutoLumat LB 953, 
Berthold) before and after stimulation with NADPH (100 μmol/L). A buffer blank was subtracted from each 
reading. The results are expressed in arbitrary units per milligram of protein, as measured by the BCA assay.
Statistical analysis. Data are expressed as mean ± SEM unless otherwise stated. Statistical comparisons 
of  parameters between groups were performed using 2-tailed Student’s t test, or 1-way and 2-way ANOVA 
followed by Bonferroni’s post hoc tests as appropriate. P < 0.05 was considered statistically significant. 
Repeated-measures ANOVA was used for comparison of  groups within vascular reactivity studies. Data 
analysis was conducted using GraphPad Prism 5.0.
Study approval. Ethics approval for the use of  human samples was obtained from the West of  Scotland 
Research Ethics Service (WS/12/0294) and from the Ethics Board of  the Ottawa Hospital Research Insti-
tute, Canada (no. 997392132). Written informed consent was obtained for all study participants in accor-
dance with the Declaration of  Helsinki. All experimental protocols using mice were performed in accor-
dance with the Ethical Principles in Animal Experimentation adopted by the West of  Scotland Research 
Ethics Service and in accordance with the United Kingdom Animals Scientific Procedures Act 1986 and 
ARRIVE guidelines and approved by the institutional ethics review committee (70/9021).
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